Diabetes
Biolinq Raises $100 Million, Unveils Micro-Sensing Technology in the Skin
This record private capital raise in the continuous glucose monitoring space includes participation from T&W Medical, AXA IM Alts, Global Health Investment Corporation, Ascensia Diabetes Care, Longevity Vision Fund, Falcon Edge Capital, Aphelion Capital, M Ventures, Hikma Ventures, Senvest, The Broe Group, Taisho Pharmaceutical, Cirrus Logic, EOFlow, Able Partners and the JDRF T1D Fund.
DreaMed Launches its FDA-Cleared Diabetes Management Platform with a Leading U.S. Children’s Hospital
Advisor Pro is the first decision support system to receive FDA clearances for Type 1 and Type 2 diabetes treatments – for pediatrics and adults.
Tandem Diabetes Care Reports Health Canada Approval of the t:slim X2 Insulin Pump with Control-IQ Advanced Hybrid Closed-Loop Technology
Tandem Diabetes Care notes all in-warranty t:slim X2 pump users in Canada will have the option to add Control-IQ technology to their existing pump beginning in March 2021 via remote software update.
In-Pen with Real-Time Connect CGM Data: 1st Integrated Smart Insulin Pen for People with Diabetes on Multiple Daily Injections
InPen is the first and only FDA-cleared smart insulin pen on the market for people on multiple daily insulin injections.
